TLR4: The First Sentinel of Innate Immunity and a Contested Target for Immunomodulatory Drugs
Once known merely as the LPS sensor, TLR4 now stands at the crossroads of adjuvant development, sepsis intervention and antitumor immunity. This article moves from the structural basis of ligand recognition to its translational value.
- Recent Advances
Keywords: TLR4,MD-2,LPS recognition,Receptor dimerization,Innate immunity,UA01001C-28
Note: The full article is published in Chinese. Please refer to the Chinese version for complete experimental details, figures and product references. For product inquiries, visit www.ua-bio.com.
This article is reviewed and published by the technical expert team of UA
Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.
Purchase recombinant protein, choose Nanjing UA-Bio
UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.
Business license (three certificates in one) 
